Evidence map›Paper›PMID 27498116›Full record

ArticleFree radical biology & medicine2016

The molecular chaperone Hsp70 promotes the proteolytic removal of oxidatively damaged proteins by the proteasome.

Sandra Reeg, Tobias Jung, José P Castro, Kelvin J A Davies, Andrea Henze, Tilman Grune

Open access · hybridAbstract read
In one paragraph

Article in Free radical biology & medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 114 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Nutrients · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Sandra ReegGerman Institute of Human Nutrition Potsdam Rehbruecke (DIfE), Department of Molecular Toxicology, 14588 Nuthetal, Germany.
Tobias JungGerman Institute of Human Nutrition Potsdam Rehbruecke (DIfE), Department of Molecular Toxicology, 14588 Nuthetal, Germany; German Center for Diabetes Research (DZD), Germany.
José P CastroGerman Institute of Human Nutrition Potsdam Rehbruecke (DIfE), Department of Molecular Toxicology, 14588 Nuthetal, Germany; German Center for Diabetes Research (DZD), Germany.
Kelvin J A DaviesUniversity of Southern California, Leonard Davis School of Gerontology, and Division of Molecular & Computational Biology, Dornsife College of Letters, Arts, and Sciences, Los Angeles, CA 90089-0191, USA.
Andrea HenzeUniversity Potsdam, Institute of Nutritional Science, Department of Physiology and Pathophysiology, 14588 Nuthetal, Germany.
Tilman GruneGerman Institute of Human Nutrition Potsdam Rehbruecke (DIfE), Department of Molecular Toxicology, 14588 Nuthetal, Germany; German Center for Diabetes Research (DZD), Germany. Electronic address: Scientific.director@dife.de.
German Institute of Human Nutrition · DEDeutsches Diabetes-Zentrum e.V. · DEUniversity of Potsdam · DEUniversity of Southern California · US

Funding

OXYGEN RADICAL TOXICITY AND RED CELL PROTEIN DEGRADATIONR01ES003598 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DAVIES, KELVIN J. A. · 1988 to 2017
$5.7M
Oxygen Radical Toxicity and Protein DegradationR56ES003598 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DAVIES, KELVIN J. A. · 2012 to 2012
$138k
NIEHS NIH HHS R01 ES003598NIEHS NIH HHS R56 ES003598
6 · The paper itself

Abstract

One hallmark of aging is the accumulation of protein aggregates, promoted by the unfolding of oxidized proteins. Unraveling the mechanism by which oxidized proteins are degraded may provide a basis to delay the early onset of features, such as protein aggregate formation, that contribute to the aging phenotype. In order to prevent aggregation of oxidized proteins, cells recur to the 20S proteasome, an efficient turnover proteolysis complex. It has previously been shown that upon oxidative stress the 26S proteasome, another form, dissociates into the 20S form. A critical player implicated in its dissociation is the Heat Shock Protein 70 (Hsp70), which promotes an increase in free 20S proteasome and, therefore, an increased capability to degrade oxidized proteins. The aim of this study was to test whether or not Hsp70 is involved in cooperating with the 20S proteasome for a selective degradation of oxidatively damaged proteins. Our results demonstrate that Hsp70 expression is induced in HT22 cells as a result of mild oxidative stress conditions. Furthermore, Hsp70 prevents the accumulation of oxidized proteins and directly promotes their degradation by the 20S proteasome. In contrast the expression of the Heat shock cognate protein 70 (Hsc70) was not changed in recovery after oxidative stress and Hsc70 has no influence on the removal of oxidatively damaged proteins. We were able to demonstrate in HT22 cells, in brain homogenates from 129/SV mice and in vitro, that there is an increased interaction of Hsp70 with oxidized proteins, but also with the 20S proteasome, indicating a role of Hsp70 in mediating the interaction of oxidized proteins with the 20S proteasome. Thus, our data clearly implicate an involvement of Hsp70 oxidatively damaged protein degradation by the 20S proteasome.

Indexed as

ProteolysisAnimalsCell LineCell SurvivalGenes, ReporterGreen Fluorescent ProteinsHippocampusHSP70 Heat-Shock ProteinsHydrogen PeroxideMaleMiceNerve Tissue ProteinsNeuronsOxidation-ReductionOxidative StressProteasome Endopeptidase ComplexATP dependent 26S proteaseGreen Fluorescent ProteinsHSP70 Heat-Shock ProteinsHydrogen PeroxideNerve Tissue ProteinsProteasome Endopeptidase ComplexProtein AggregatesChaperoneHSP70ProteasomeProtein oxidation

Identifiers

PMID27498116
PMCPMC5201141
OpenAlexW2496447860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.